The Pharmaceutical Journal
Vol 279 No 7466 p200
25 August 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Sodium cromoglicate

Galpharm has asked the Medicines and Healthcare products Regulatory Agency to reclassify sodium cromoglicate 2 per cent eye-drops from a pharmacy medicine to a general sale list medicine.

Comments on the application can be sent to the MHRA until 8 October 2007.